Are there differences in risk factor profiles and frequency of CT/ MRI-based infarcts among African American stroke patients with and without hypertension? A report from the African American Antiplatelet Stroke Prevention Study (AAASPS)

Journal of the National Medical Association

Volumn 95, Issue 6, 2003, Pages 423-432

  Whittley, Chandra Y ^a   Gorelick, Philip B ^a   Raman, Rema ^a   Harris, Jeffrey ^a   Richardson, DeJuran ^a  

^a Dept of Neurological Science ^*

Author keywords

CT MRI; Hypertension; Stroke

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BRAIN INFARCTION; CARDIOVASCULAR RISK; CIGARETTE SMOKING; COMPUTER ASSISTED TOMOGRAPHY; CONFIDENCE INTERVAL; DIABETES MELLITUS; EDUCATION; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NEGRO; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR; SEX DIFFERENCE; STROKE; AFRICAN AMERICAN; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; ETHNOLOGY; HEART INFARCTION; MIDDLE AGED; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; STATISTICAL MODEL; STATISTICS; UNITED STATES;

AFRICAN AMERICANS; CEREBROVASCULAR ACCIDENT; FEMALE; HUMANS; HYPERTENSION; LOGISTIC MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREVALENCE; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED; UNITED STATES;

EID: 0042736519     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Gorelick PB. Cerebrovascular disease in African Americans. Stroke. 1998;29:2656-2664.
2. Gillum RF. Epidemiology of stroke in blacks. In: Gillum RF, Gorelick PB, Cooper ES (eds): Stroke In Blacks, A Guide to Management and Prevention. Karger, New York, 1999, p. 83-93.
3. Morgenstern LB, Spears WD, Goff DC, Grotta JC, Nichaman MZ. African Americans and women have the highest stroke mortality in Texas. Stroke. 1997;28:15-18.
4. Howard G, Evans GW, Pearle K, Howard VJ, Bell RA, Mayer EJ, Burke GL. Is the stroke belt disappearing? An analyses of racial, temporal, and age effects. Stroke. 1995;26:1153-1158.
5. Gillum RF. Stroke mortality in blacks. Disturbing trends. Stroke. 1999;30:1711-1715.
6. Broderick J, Brott T, Kothari R, Miller R, Khoury J, Pancioli A, Gebel J, Mills D, Minneci L, Shukla R. The Greater Cincinnati/Northern Kentucky Stroke Study: preliminary first-ever and total incidence rates of stroke among blacks. Stroke. 1998;29:415-421.
7. Sacco RL, Boden-Albala B, Gan R, Chen Y, Kargman DE, Shea S, Paik MC, Hauser WA, for the Northern Manhattan Stroke Study Collaborators. Stroke incidence among white, black and Hispanic residents of an urban community: the Northern Manhattan Stroke Study. Am J Epidemiol. 1998;147:259-268.
8. Giles WH, Kettner SJ, Hebel JR, Losconczy KG, Sherwin RW. Determinants of black-white differences in the risk of cerebral infarction: the National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Arch Intern Med. 1995;155:1319-1324.
9. Friday G. Lai SM, Alter MA, Sobel E, LaRue E, Gil-Peralta A, McCoy RL, Lewitt LP, Isack T. Stroke in the Lehigh Valley: racial/ethnic differences. Neurology. 1989;39:1165-1168.
10. Gorelick PB, Harris Y. Stroke: an excess burden on African Americans. Chicago Med. 1993;96:28-30.
11. Gaines K, Burke G, for the SECORDS Investigators. Ethnic differences in stroke: black-white differences in the United States population. Neuroepidemiology. 1995;14:209-239.
12. Connett J, Stamler T. Responses of blacks and whites to special intervention of the MRFIT. Am Heart J. 1984;108:839-848.
13. Ford Lynch G, Leurgans S, Raman R, Barboi A, Gorelick PB. A comparison of stroke risk factors in patients enrolled in stroke prevention trials. J Natl Med Assoc. 2001;93:79-80.
14. Gorelick PB, Leurgans S, Richardson D, et al. African American antiplatelet stroke prevention study: clinical trial design. J Stroke and Cerebrovascular Diseases, 1998;7:426-434.
15. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) investigators. Low molecular weight heparinoid ORG 10172 (danaparoid), and outcome after acute ischemic stroke. A randomized, controlled trial. JAMA. 1998;279:1265-1272.
16. Kannel WB. Blood pressure as a cardiovascular risk factor. Prevention and treatment. JAMA. 1996;275:1571-1576.
17. Dammerman M, Breslow JL. Genetic determinants of myocardial infarction. In: Manson JE, Ridker PM, Gaziano JM, Hennekens CH: Prevention of Myocardial Infarction, Oxford University Press, New York, 1996, p. 76-78.
18. Gorelick PB, Sacco RL, Smith DB, Alberts M, Mustone-Alexander L, Rader D, Ross JL, Raps E, Ozer MN, Brass LM, Malone ME, Goldhesog S, Booss J, Hanley DF, Toole JF, Greengold NL, Rhew DC. Prevention of a first stroke. A review of guidelines and a multidisciplinary consensus statement from the National Stroke Association. JAMA. 1999;281:1112-1120.
19. Goldstein LB, Adams R, Becker K, Furberg CD, Gorelick PB, Hademenos G, Hill M, Howard G, Howard J, Jacobs B, Levine SR, Mosca L, Sacco RL, Sherman DG, Wolf PA, del Zofpo GJ. Primary prevention of ischemic stroke. Ad Loc writing group from the Stroke Council of the American Heart Association. Stroke. 2001;32:280-299.
20. Becker C, Howard G, McLeroy KR, et al. Community hospital-based stroke programs: North Carolina, Oregon and New York. II: Description of study population. Stroke. 1986;17:385-393.
21. Heyman A, Fields WS, Keating DR. Joint Study of Extracranial Arterial Occlusion, VI: Racial differences in hospitalized patients with ischemic stroke. JAMA. 1972;222:285-289.
22. Kuhlemeier KV, Stiens SH. Racial disparities in severity of cerebrovascular events. Stroke. 1994;25:3126-2131.
23. Goldstein L, Hoenig H. Stroke Rehabilitation in African American Patients. In: Gillum R, Gorelick PB, Cooper ES (eds): Stroke In Blacks. A Guide to Management and Prevention. Karger, New York, 1999:198-209.
24. Sacco RL, Wolf PA, Gorelick PB. Risk factors and their management for stroke prevention: outlook for 1999 and beyond. Neurology. 1999;53 (Supp 4):515-524.
25. Sacco RL, Shi T, Zamanillow MC, Kargman D. Predictors of mortality and recurrence after hospitalized cerebral infarction in an urban community: the Northern Manhattan Stroke Study. Neurology. 1994;44:626-634.
26. Rundeck T, Elkind M, Chen Y, Boden-Albala B, Paik MC, Sacco RL. Increased early stroke recurrence among patients with extracranial and intracranial atherosclerosis: the Northern Manhattan Stroke Study (Abstract), Neurology, 1998;50: (Suppl 4): A75.
27. Rundeck T, Chen Y, Steiner MM, et al. Predictors of early stroke recurrence: the Northern Manhattan Stroke Study (Abstract). Cerebrovasc Dis. 1997;7 (Supp 4):1-88.
28. Sacco RI, Foulkes MA, Mohr JP, Wolf PA, Hier DB, Paice TR. Determinants of early recurrence of cerebral infarction: the Stroke Data Bank. Stroke. 1989;20:983-989.
29. Hier DB, Foulker MA, Swcontoncowrki M, Sacco RL, Gorelick PB, Mohr JP, Price TR, Wolf PA. Stroke recurrence within two years after ischemic infarction. Stroke. 1991;22:155-161.
30. PROGRESS Collaborative Group. Randomized trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischemic attack. Lancet. 2001;358:1033-41.